Week in review: How Trump's policies moved stocks

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump and his administration with this weekly recap compiled by The Fly: 1. ZTE: Shares of Acacia Communications (ACIA) and Oclaro (OCLR), both suppliers to ZTE Corp. (ZTCOY), were in the spotlight on Monday after President Donald Trump tweeted that he was working to give the Chinese tech company a "way to get back into business." "President Xi of China, and I, are working together to give massive Chinese phone company, ZTE, a way to get back into business, fast. Too many jobs in China lost. Commerce Department has been instructed to get it done!," the President tweeted. This comes after the U.S. Department of Commerce recently banned U.S. companies from selling components to ZTE for seven years for violating the terms of a sanctions violation case. According to a report by The Wall Street Journal on Sunday, ZTE told U.S. authorities that failure to fully comply with a settlement agreement resolving sanctions-busting charges was due to faults in the company's internal controls, not deception. Subsequently, late on Wednesday, Trump tweeted: "The Washington Post and CNN have typically written false stories about our trade negotiations with China. Nothing has happened with ZTE except as it pertains to the larger trade deal. Our country has been losing hundreds of billions of dollars a year with China. We have not seen China's demands yet, which should be few in that previous U.S. Administrations have done so poorly in negotiating. China has seen our demands. There has been no folding as the media would love people to believe, the meetings... haven't even started yet! The U.S. has very little to give, because it has given so much over the years. China has much to give!" 2. TOSHIBA A SIGN? Another tech company, Toshiba (TOSBF), is being pointed to as a signal that trade deal progress is being made, as Reuters reported late in the week, citing Japanese public broadcaster NHK, that regulatory authorities in China have given the green light to the proposed $18B sale of Toshiba's chip unit to a Bain Capital-led consortium. 3. APPLE CEO: On Tuesday, Apple's (AAPL) CEO Tim Cook said in an interview on Bloomberg Television that he criticized President Donald Trump's approach to trade with China in a recent White House meeting, saying his message to Trump focused on the importance of trade and how cooperation between the nations could boost the economy more than the countries acting alone. 4. DRUGMAKER 'SHAME' LIST: On Thursday, the FDA, working toward the Trump Administration's priority of advancing policies that increase competition as a way to help make drugs more affordable, made public a list of companies that have potentially been blocking access to the samples of their branded products in hopes the "increased transparency will help reduce unnecessary hurdles to generic drug development and approval." Among the many drugmakers on the FDA's list are: Valeant (VRX), Pfizer (PFE), Biogen (BIIB), Insys Therapeutics (INSY), VIVUS (VVUS), Celgene (CELG), Bayer (BAYRY), Gilead (GILD), BioMarin (BMRN), Novelion Therapeutics (NVLN) - formerly Aegerion, Mallinckrodt's (MNK) Questcor, Shire (SHPG), Merck's (MRK) Cubist, Jazz Pharmaceuticals (JAZZ), Teva (TEVA), AstraZeneca (AZN), Acorda Therapeutics (ACOR), Mylan (MYL), Novartis (NVS), Roche (RHHBY) and Galena (GALE). 5. EMISSIONS RULES: The Trump administration's EPA is not intending to give special treatment to California while it drafts new federal rules on vehicle emissions, despite President Donald Trump's suggestions last week that his team would work on a deal with the state, The Wall Street Journal reported, citing people familiar with the matter. Publicly traded companies in the space include Daimler AG (DDAIF), Fiat Chrysler (FCAU), Ford (F), General Motors (GM), Honda (HMC), Nissan (NSANY), Toyota (TM) and Volkswagen (VLKAY). "Week in Review" is The Fly's weekly recap of its recurring series of "Trump Effect" exclusive stories.